Core Scientific (NASDAQ:CORZ) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says

Core Scientific (NASDAQ:CORZ) had its price target increased by analysts at Canaccord Genuity Group from $17.00 to $20.00 in a research note issued on Wednesday, MarketBeat Ratings reports. The firm presently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective would suggest a potential upside of 25.00% from the company’s current price.

Other equities research analysts have also recently issued research reports about the company. Weiss Ratings restated a “sell (d-)” rating on shares of Core Scientific in a research note on Wednesday, January 21st. Needham & Company LLC raised shares of Core Scientific from a “hold” rating to a “buy” rating and set a $23.00 target price for the company in a report on Tuesday. Zacks Research raised shares of Core Scientific from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 13th. BTIG Research raised Core Scientific from a “neutral” rating to a “buy” rating and set a $23.00 price target on the stock in a research report on Tuesday, January 6th. Finally, LADENBURG THALM/SH SH dropped their target price on shares of Core Scientific from $24.50 to $23.75 and set a “buy” rating for the company in a research report on Tuesday. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, three have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, Core Scientific currently has an average rating of “Moderate Buy” and an average price target of $24.84.

Core Scientific Stock Up 1.0%

Shares of NASDAQ CORZ opened at $16.00 on Wednesday. Core Scientific has a twelve month low of $6.20 and a twelve month high of $23.63. The stock has a market cap of $5.05 billion, a price-to-earnings ratio of 13.68 and a beta of 6.87. The company’s fifty day moving average is $17.28 and its 200-day moving average is $16.95.

Core Scientific (NASDAQ:CORZ) last released its quarterly earnings results on Monday, March 2nd. The company reported $0.42 EPS for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.69. The business had revenue of $79.76 million for the quarter, compared to analyst estimates of $118.45 million. The company’s revenue for the quarter was down 16.0% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.69) EPS. On average, research analysts anticipate that Core Scientific will post 0.52 EPS for the current fiscal year.

Hedge Funds Weigh In On Core Scientific

Several institutional investors have recently made changes to their positions in the stock. AQR Capital Management LLC lifted its holdings in shares of Core Scientific by 106.1% in the first quarter. AQR Capital Management LLC now owns 283,432 shares of the company’s stock valued at $2,052,000 after purchasing an additional 145,905 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in Core Scientific by 180.9% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,109,387 shares of the company’s stock valued at $8,032,000 after buying an additional 714,388 shares during the last quarter. Nisa Investment Advisors LLC lifted its stake in Core Scientific by 192.3% during the 2nd quarter. Nisa Investment Advisors LLC now owns 4,662 shares of the company’s stock valued at $80,000 after acquiring an additional 3,067 shares in the last quarter. Teacher Retirement System of Texas boosted its holdings in Core Scientific by 31.4% during the 2nd quarter. Teacher Retirement System of Texas now owns 42,543 shares of the company’s stock worth $726,000 after acquiring an additional 10,161 shares during the last quarter. Finally, Amalgamated Bank boosted its holdings in Core Scientific by 52.2% during the 2nd quarter. Amalgamated Bank now owns 9,423 shares of the company’s stock worth $161,000 after acquiring an additional 3,231 shares during the last quarter.

Core Scientific News Summary

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: HC Wainwright reiterated a Buy, materially raised FY2026 EPS (from $0.16 to $0.33) and published quarterly EPS estimates with a $25 price target — a clear analyst endorsement that supports the rally. HC Wainwright Reiterates Buy
• Positive Sentiment: Canaccord raised its price target from $17 to $20 and maintained a Buy rating, adding upward price-target momentum. Canaccord PT Raised to $20
• Positive Sentiment: MarketBeat and other coverage argue the company’s pivot to AI colocation (including a reported $10B+ backlog and rapid colocation growth) creates multi-year upside and institutional buying support, which can drive investor interest despite short-term churn. Core Scientific’s $10 Billion AI Shift
• Neutral Sentiment: CoreWeave contract progress: reports note the CoreWeave deal is ahead of schedule and colocation revenue is ramping, a structural positive; however, this is balanced by transitional revenue mix changes. CoreWeave Deal Ahead of Schedule
• Neutral Sentiment: Short-interest data in recent filings shows anomalous “0 shares” readings (likely a reporting glitch); current days-to-cover appears negligible — this item is noisy and should not be overinterpreted.
• Negative Sentiment: Q4 2025 results showed revenue weakness (reported as a 38% YoY decline in one summary) and a sharp earnings swing tied to the pivot, which earlier drove a significant intraday drop. Investors remain sensitive to near-term top-line contraction and negative adjusted EBITDA while expansion investments continue. Core Scientific 2025 earnings: revenue falls 38% YoY
• Negative Sentiment: At least one firm (Ladenburg Thalmann) lowered expectations, reflecting some analyst caution on near-term execution risks and balance-sheet concerns tied to the transition. Ladenburg Lowers Expectations

About Core Scientific

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.